Hypertension Medicines Approved in the EU (EMA)

• 70medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 29May2026

  Bopediat

  Active substance: furosemide

  EMEA/H/C/006617
• 21Nov2025

  Svariya (previously Rivaroxaban Koanaa)

  Active substance: rivaroxaban

  EMEA/H/C/006643
• 24Sep2025

  Macitentan Accord

  Active substance: macitentan

  EMEA/H/C/006524
• 24Sep2025

  Macitentan AccordPharma

  Active substance: macitentan

  EMEA/H/C/006523
• 27Sep2024

  Yuvanci

  Active substance: macitentan;tadalafil

  EMEA/H/C/005001
• 22Aug2024

  Winrevair

  EMEA/H/C/005647
• 15Nov2023

  Catiolanze

  Active substance: Latanoprost

  EMEA/H/C/005933
• 26May2023

  Qaialdo

  Active substance: spironolactone

  EMEA/H/C/005535
• 6Jan2022

  Wegovy

  Active substance: semaglutide

  EMEA/H/C/005422
• 7Jan2021

  Roclanda

  Active substance: Latanoprost;netarsudil mesilate

  EMEA/H/C/005107
• 16Nov2020

  Rivaroxaban Accord

  Active substance: rivaroxaban

  EMEA/H/C/005279
• 23Jul2020

  Apixaban Accord

  Active substance: apixaban

  EMEA/H/C/005358
• 3Apr2020

  Trepulmix

  Active substance: treprostinil sodium

  EMEA/H/C/005207
• 19Nov2019

  Rhokiinsa

  Active substance: netarsudil

  EMEA/H/C/004583
• 20Jun2019

  Ambrisentan Viatris (previously Ambrisentan Mylan)

  Active substance: ambrisentan

  EMEA/H/C/004985

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• High blood pressure (ages 30–79)

• Cardiovascular
• Diabetes
• Maternal